Delivery Order SPE2DR25D3103-SPE2DR26F0A5L
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $21,775.72 to AmerisourceBergen Drug Corp for the supply of Adacel TDAP syringes (0.5mL) with an ultimate completion date of October 22, 2025. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor and critical federal healthcare vendor, regularly supplies...
- The Defense Logistics Agency awarded a $11,375 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP syringes (0.5 mL) with an ultimate completion date of December 5, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The place of performance is listed as the company's corporate office in...
- The Defense Logistics Agency awarded a $33,190.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP Syringe 0.5ML with an ultimate completion date of August 25, 2025. This is a competitively awarded contract with no set-aside designation, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $46,590.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP syringes (0.5mL) with an ultimate completion date of July 28, 2025. This competitively awarded, non-set-aside delivery order represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a $33.5K delivery order to AmerisourceBergen Drug Corp for Adacel TDAP syringes (0.5mL) under a firm fixed-price contract with a completion date of September 4, 2025. This non-set-aside competitive award leverages AmerisourceBergen's position as a critical pharmaceutical and medical supply vendor for federal healthcare procurement. The order was placed to the company's corporate office location in Conshohocken, Pennsylvania, where the company is headquartered...
- The Defense Logistics Agency awarded a $1,340.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Adacel TDAP syringes (0.5mL) on July 25, 2025, with an ultimate completion date of July 28, 2025. This is a non-set-aside competitive award, and AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP Syringe 0.5ML on September 12, 2025, with a ceiling value of $16,221.54 and firm fixed pricing. This non-set-aside, competitively awarded contract represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $20,435.72 delivery order to AmerisourceBergen Drug Corp for 0.5ML Adacel TDAP syringes under a firm fixed price contract structure. The award was made on October 30, 2025, with an ultimate completion date of October 31, 2025, and does not include a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a small transaction...
- The Defense Logistics Agency awarded a $1,072.00 delivery order to AmerisourceBergen Drug Corp for Adacel TDAP syringes (0.5ML) on August 6, 2025, with completion scheduled for August 7, 2025. This is a firm fixed-price contract with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a routine pharmaceutical procurement through the federal medical supply chain, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a $15,084.90 delivery order to AmerisourceBergen Drug Corp for Adacel TDAP syringes (0.5mL) on May 14, 2025, with completion scheduled for May 15, 2025. This non-set-aside contract employs firm fixed-price pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine medical supply procurement under AmerisourceBergen's existing federal contract framework with the Defense Logistics...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F0A5LDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $34,125 to AmerisourceBergen Drug Corp for the supply of Adacel TDAP syringes (0.5ml) with an ultimate completion date of January 28, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. This delivery order operates under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999 through December 31, 2031. This comprehensive IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The present award reflects the contractor's capability to efficiently fulfill government contracts for essential medical commodities required by military treatment facilities and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.1k | 1/26/26 |